Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078919 | SCV000110779 | pathogenic | not provided | 2012-09-28 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000672527 | SCV000797639 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2018-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001854392 | SCV002108571 | pathogenic | Zellweger spectrum disorders | 2023-09-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln744*) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is present in population databases (rs398123409, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 93104). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003474678 | SCV004203274 | pathogenic | Heimler syndrome 1 | 2024-03-16 | criteria provided, single submitter | clinical testing |